Your browser doesn't support javascript.
loading
SAUL, a single-arm study of atezolizumab for chemotherapy-pretreated locally advanced or metastatic carcinoma of the urinary tract: outcomes by key baseline factors, PD-L1 expression and prior platinum therapy.
Bamias, A; Merseburger, A S; Loriot, Y; James, N; Choy, E; Castellano, D; Lopez-Rios, F; Calabrò, F; Kramer, M; de Velasco, G; Zakopoulou, R; Tzannis, K; Sternberg, C N.
Afiliação
  • Bamias A; Second Propaedeutic Department of Internal Medicine, ATTIKON University Hospital, National & Kapodistrian University of Athens, Athens, Greece. Electronic address: abamias@med.uoa.gr.
  • Merseburger AS; Department of Urology, University Clinic Schleswig-Holstein-Lu¨beck, Lu¨beck, Germany.
  • Loriot Y; Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France.
  • James N; Institute of Cancer Research, The Royal Marsden Hospital NHS Foundation Trust, London.
  • Choy E; CREATE Centre, Division of Infection and Immunity, Cardiff University, Cardiff, UK.
  • Castellano D; Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Lopez-Rios F; Pathology Laboratory of Therapeutic Targets, HM Sanchinarro University Hospital, Madrid, Spain.
  • Calabrò F; GU Oncology Unit, San Camillo and Forlanini Hospital, Rome, Italy.
  • Kramer M; Department of Urology, University Clinic Schleswig-Holstein-Lu¨beck, Lu¨beck, Germany.
  • de Velasco G; Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Zakopoulou R; Clinical Therapeutics, University of Athens, Athens, Greece.
  • Tzannis K; Second Propaedeutic Department of Internal Medicine, ATTIKON University Hospital, National & Kapodistrian University of Athens, Athens, Greece.
  • Sternberg CN; Englander Institute for Precision Medicine, Department of Medical Oncology, Weill Cornell Medicine, Meyer Cancer Center, New York, USA.
ESMO Open ; 6(3): 100152, 2021 06.
Article em En | MEDLINE | ID: mdl-33984672

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Sistema Urinário / Carcinoma de Células de Transição Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: ESMO Open Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Sistema Urinário / Carcinoma de Células de Transição Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: ESMO Open Ano de publicação: 2021 Tipo de documento: Article